CSI Cardiovascular Systems, Inc., Diamondback 360 Peripheral Orbital Atherectomy System, Model Number DBP-125MICRO145, Part Number 7-10003. The Diamondback 360 Peripheral Orbital Atherectomy System is a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and who are acceptable candidates for percutaneous transluminal atherectomy. The OAS supports removal of stenotic material from artificial arteriovenous dialysis fistulae (AV shunt). The system is a percutaneous orbital atherectomy system indicated as a therapy in patients with occluded hemodialysis grafts who are acceptable candidates for percutaneous transluminal angioplasty.
Publicado el 20 de agosto de 2014 · Inicio del retiro: 23 de mayo de 2014
Resumen
FDA registra el retiro Z-2155-2014 de dispositivos médicos de Clase I, publicado el 20 de agosto de 2014 e iniciado el 23 de mayo de 2014. Empresa responsable: Cardiovascular Systems, Inc.; Estado: Finalizado; Cantidad reportada: 48; Lote: 100573, 100575, 100674, 100676, 100678, 100680. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
CSI has initiated a recall on the Diamondback 360 Peripheral Orbital Atherectomy Device because it may contain a saline sheath that may experience cracking, fracture, and release particulate during use.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Cardiovascular Systems, Inc.
- Distribuidor
- Nationwide Distribution including AZ, AR, CA, CT, FL, IL, IA, MD, MI, NY, NC, PA, TN,and TX.
- Lote
- 100573, 100575, 100674, 100676, 100678, 100680.
- Clasificación de riesgo
- Class I
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDADiamondback 360 Coronary Orbital Atherectomy System, Model Number: DBEC-125. The system is indicated to1 de abril de 2015
- FDAEnhancement Medical expression. model # EXP-150. Injectable Gel 1.5cc Syringe with hyaluronic acid20 de agosto de 2014
- FDAEsaote PA230E Transducer A portable and cart base ultrasound system for general and cardiovascular imaging20 de agosto de 2014
- FDAGYC-1000 Green Laser Photocoagulator system The Nidek Green Laser Photocoagulator Model GYC -1000 is indicated20 de agosto de 2014
- FDACSI, Diamondback 360 Coronary Orbital Atherectomy System, Part Number 70058-02, Model Number DBEC-125 Product5 de marzo de 2014
- FDACSI Stealth 360-degree Orbital Atherectomy Device (OAD), Part Number 70056-11, Model Number PRD-SC30-125S.18 de julio de 2012
Preguntas sobre este retiro
¿CSI Cardiovascular Systems, Inc., Diamondback 360 Peripheral Orbital Atherectomy System, Model Number DBP-125MICRO145, Part Number 7-10003. The Diamondback 360 Peripheral Orbital Atherectomy System is a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and who are acceptable candidates for percutaneous transluminal atherectomy. The OAS supports removal of stenotic material from artificial arteriovenous dialysis fistulae (AV shunt). The system is a percutaneous orbital atherectomy system indicated as a therapy in patients with occluded hemodialysis grafts who are acceptable candidates for percutaneous transluminal angioplasty. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2155-2014 el 20 de agosto de 2014. Peligro reportado: CSI has initiated a recall on the Diamondback 360 Peripheral Orbital Atherectomy Device because it may contain a saline sheath that may experience cracking, fracture, and release particulate during use.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter